Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03935555
Title Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Samus Therapeutics, Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Marin Cancer Care - Greenbrae (California Cancer Care A Medical Group, Inc. - Greenbrae) Larkspur California 94904 United States Details
Ronald Reagan UCLA Medical Center Los Angeles California 90095 United States Details
MD Anderson Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field